Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
28.69 USD | +2.14% | +0.95% | +2.83% |
Summary
- On the basis of various fundamental qualitative criteria, the company appears to be particularly poorly ranked from a medium and long-term investment perspective.
- Overall, and from a short-term perspective, the company presents an interesting fundamental situation.
- The company has a good ESG score relative to its sector, according to Refinitiv.
Strengths
- Its low valuation, with P/E ratio at 8.64 and 8.41 for the ongoing fiscal year and 2025 respectively, makes the stock pretty attractive with regard to earnings multiples.
- Analysts remain confident with respect to the group's activity and, more often than not, have revised upwards their earnings per share estimates.
- Analyst opinion has improved significantly over the past four months.
- Considering the small differences between the analysts' various estimates, the group's business visibility is good.
- Analysts' price targets are all relatively close, reflecting good visibility on the company's valuation.
Weaknesses
- According to Standard & Poor's' forecast, revenue growth prospects are expected to be very low for the next fiscal years.
- For the last four months, the sales outlook for the coming years has been revised downwards. No recovery of the group's activities is yet foreseen.
- Over the past twelve months, analysts' consensus has been significantly revised downwards.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Life & Health Insurance
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+2.83% | 3.11B | A- | ||
+12.07% | 78.88B | B- | ||
+9.44% | 51.46B | B+ | ||
+8.93% | 51.07B | B | ||
+20.90% | 46.59B | B+ | ||
+16.04% | 43.21B | B+ | ||
+23.53% | 39.69B | B | ||
-0.60% | 29.1B | B | ||
-6.79% | 27.94B | B- | ||
-15.80% | 26.05B | A- |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- CNO Stock
- Ratings CNO Financial Group, Inc.